The MHRA has licensed brensocatib as the first disease-specific therapy for non-cystic fibrosis bronchiectasis in patients with recurrent exacerbations.

Brensocatib is the first medicine of its kind to be approved in the UK for preventing flare‑ups in NCFB. It works by blocking ...

Liu, Y. and Huang, Y. (2026) Advances in CT-Based Diagnosis of Pneumonic-Type Lung Cancer: A Review. Journal of Biosciences and Medicines, 14, 448-456. doi: 10.4236/jbm.2026.142033 .

The Medicines and Healthcare products Regulatory Agency has granted marketing authorisation for brensocatib, branded as Brinsupri, marking the first time a medicine specifically designed to treat ...

Bhopal: With board exams and college tests underway and rise in OPD admissions in city hospitals, doctors are warning of a surge in post-viral bronchi.

Smoking is the leading cause of chronic bronchitis. Acute bronchitis is usually caused by viral infections of the bronchi. Chronic bronchitis develops through long-term exposure to inhaled toxins.

In her white lab coat, Megan Koster, divisional dean of the new School of Respiratory Care Sciences, leads two respiratory care students in a simulated intubation. Marking 50 years of respiratory care ...

Abstract: Segmentation of the pulmonary lobes is relevant in clinical practice and particularly challenging for cases with severe diseases or incomplete fissures. In this work, an automated ...

SINCE Laennec 1 first described and named bronchiectasis its etiology and mode of development have been controversial issues. Numerous theories have been advanced, each of which is backed by ...

The bronchi are tubes that carry air from the trachea to the lungs and back out. The bronchi help trap and remove germs that can make you sick. Bronchitis, asthma, and COPD are some conditions that ...

Bronchiectasis hospitalizations have higher mortality and costs than COPD and asthma, with a median stay of 5 days and costs of $50,393. During the COVID-19 pandemic, bronchiectasis hospitalizations ...

BRIDGEWATER, N.J., 18 November, 2025 /PRNewswire/ - Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver therapies to transform the lives of patients ...